. Author manuscript; available in PMC: 2017 Jul 15.

Published in final edited form as: J Affect Disord. 2016 Apr 13;199:148–156. doi: 10.1016/j.jad.2016.04.017

Table 1.

Prediction of Psychosocial Functioning through Acute, Continuation, and Follow-up Phases

Measure	Assessment time main effect			Continuation treatment main effect			Treatment × time interaction
Measure	df	F	p	df	F	p	df	F	p
SAS-SR	9,1157	133.92	<.001	2,236	0.21	.809	18,1157	1.27	.199
IIP	9,1164	86.64	<.001	2,237	1.90	.152	18,1164	1.04	.415
DYS	9,606	8.23	<.001	2,148	0.32	.728	18,606	1.05	.401
RIFT	33,4105	38.22	<.001	2,237	0.05	.948	66,4105	0.97	.536

Note. N = 241 patients who had higher-risk response to acute-phase cognitive therapy and were randomized to 8 months of continuation treatment (cognitive therapy, fluoxetine, or placebo) and followed up to 24 additional months. For the Social Adjustment Scale—Self-Report (SAS-SR), Inventory of Interpersonal Problems (IIP), and Dyadic Adjustment Scale (DYS), 10 assessments occurred at intake to acute-phase cognitive therapy and approximately every 4 months thereafter. For the Range of Impaired Functioning Tool (RIFT), functioning estimates were computed at acute-phase intake, randomization, and for each month 1–32 after randomization. Tabled results are from repeated-measures multilevel models. Multilevel models controlled receipt of non-protocol treatment.